Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia. - Wikidata - awgldk - TriplyDB

Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.

Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.

http://www.wikidata.org/entity/Q48534275

about

Reliability, validity and clinical correlates of the Quality of Life in Alzheimer’s disease (QoL-AD) scale in medical inpatients Parkinson's Disease and Cognitive Impairment Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementias Outcome measures for Parkinson's disease dementia: a systematic review.Potentially inappropriate medications in the elderly: a comprehensive protocol.Drug treatments for the neuropsychiatric complications of Parkinson's disease.Neurobiology of cognitive impairment in Parkinson's disease.Neuropsychiatric Issues in Parkinson's Disease.Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives.Memantine improves goal attainment and reduces caregiver burden in Parkinson's disease with dementia.Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia.NMDA antagonists for treating the non-motor symptoms in Parkinson's disease.

P2860

Q24658417-9F25320B-5BB8-42B1-BC07-BE4953023633 Q30239814-AE2CFF89-A131-4FB4-831B-D96AD3B707E9 Q33879213-A72B2D48-AF34-4D87-BA94-449B95C57ABA Q34528182-C952A347-1BCC-4723-BB71-2B0A6B5089D5 Q36688859-F550C575-3E30-42E3-BE08-33829F9D1253 Q37987859-88EA65AF-AA35-4B37-B640-9996A99A2F92 Q38067142-2933604D-B0D6-4B5F-A6D7-3117C6ACA7E6 Q38067143-091BA759-CD7B-41CA-AD71-755046D6058F Q38799051-72EA8E5D-15A9-491A-A70F-432F630956BF Q47673497-EF4AE744-5C7D-4B1C-ADD8-1A690F0E225B Q47801241-E71B2FE9-7FA7-40C4-9162-EAF22EF2F05D Q48642615-268F9859-363A-4B17-AB31-A0FF178CAD7E Q55474333-5B6292E2-C962-44D0-8AB5-AC0BF5270CD8

P2860

Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.

http://www.wikidata.org/entity/Q48534275

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Quality of life and the effect ...... Parkinson's disease dementia.

@en

Quality of life and the effect ...... Parkinson's disease dementia.

@nl

type

label

Quality of life and the effect ...... Parkinson's disease dementia.

@en

Quality of life and the effect ...... Parkinson's disease dementia.

@nl

prefLabel

Quality of life and the effect ...... Parkinson's disease dementia.

@en

Quality of life and the effect ...... Parkinson's disease dementia.

@nl

P1433

Q48534275-8C69D842-31A4-421A-856A-52D5F6BFF85D

P1476

Q48534275-DC661AFB-7DB3-4048-B295-E209530F6B83

P2093

Q48534275-20E6E11C-4AE7-4A2A-BA9D-DD7D5BABAA6D

Q48534275-91369354-619F-45AA-BAA1-49FC54BD88C6

P2860

Q48534275-03D4952E-6C20-43FC-BEC7-1FEF057107CE

Q48534275-0FE150C7-A75C-419F-9F2B-5174F4E52F49

Q48534275-11428610-CA84-43E4-ADE4-B600A4CA66D0

Q48534275-1E7EBD1A-E1E4-44BB-BFD2-D58FDA3EE5B0

Q48534275-254BE369-C9FA-4300-ADB1-F2A91E0CBC19

Q48534275-2558A2AA-9B0A-4438-8812-ED191C65030B

Q48534275-255AC904-A02A-474A-96D4-E33158D5D188

Q48534275-25DA3E74-5B96-4F01-923D-5D6C97F145C5

Q48534275-341A1ABA-3338-4E02-A7C5-87274E0AE088

Q48534275-3DF982D8-D202-4CA1-BD77-2F42D1AB09D0

P304

Q48534275-86364B74-237A-4B4C-8E2C-934E40591E53

P31

Q48534275-28C51AAF-9727-4EDF-A16D-C2F6851A0AF6

P356

Q48534275-53121406-DF24-4DA9-B2A3-96A262CAC726

P433

Q48534275-C449D588-3162-42AD-BD33-E035F69F2F71

P478

Q48534275-4195C279-4A85-4284-AE33-5D1532F8D2D8

P50

Q48534275-23938E28-490B-46ED-B386-D644558BC931

Q48534275-454FC526-9884-4931-8A58-74190B53C3A5

Q48534275-DE42D6B3-118A-435C-A945-D22F3965634B

Q48534275-EC767D33-AD86-4690-8667-0CD77AC15CCE

P577

Q48534275-8451C42E-F7FE-4968-AB7F-AE37D28D18AC

P698

Q48534275-651DDCD8-0A00-4572-AE1F-BE56B3068F8B

P921

Q48534275-6C3B0E98-4276-49AF-BF11-8C1B1D4F2FEC

Q48534275-A29ED2A5-FE13-4C6C-9E2E-83A087A5B4B5

P356

P1433

Dementia and Geriatric Cognitive Disorders

P1476

Quality of life and the effect ...... Parkinson's disease dementia.

@en

P2093

Carina Wattmo

http://www.w3.org/2001/XMLSchema#string

Victoria Larsson

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

The use of Goal Attainment Scaling in a community health promotion initiative with seniors.

Factor structure and invariance of the Quality of Life in Alzheimer's Disease (QoL-AD) Scale

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.

Rivastigmine for dementia associated with Parkinson's disease.

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease.

Quality of life in dementia: more than just cognition. An analysis of associations with quality of life in dementia.

The clinical significance of adaptation to changing health: a meta-analysis of response shift.

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.

P304

227-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000334523

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Lennart Minthon

Elisabet Londos

P577

2011-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22122992

http://www.w3.org/2001/XMLSchema#string

P921

quality of life